OBJECTIVES: The aim of this study was to investigate the technical success and efficacy of mitral valve edge-to-edge repair using extended clip arms. BACKGROUND: A new iteration of the MitraClip system, the MitraClip XTR, was introduced in 2018 with the aim of addressing technical limitations observed with previous versions. METHODS: Patients having received at least 1 new implant for the treatment of symptomatic mitral regurgitation (MR) were eligible for this study. RESULTS: Among the 107 patients (mean age 76 ± 9 years, 69% men) included in this study, the etiology of MR was balanced, with one-half (n = 53 [50%]) classified as secondary and the remaining 54 patients having either primary (n = 40 [37%]) or mixed (n = 14 [13%]) disease. The mean number of devices implanted was 1.5 ± 0.6. Multiple device implantation was required in 46 patients (43%). Single-leaflet device attachment occurred in 4 patients and leaflet injury in 2 additional patients, requiring surgical conversion in 4 patients. Among the 102 patients discharged alive without mitral valve surgery, 95 (93%) had MR ≤2+ and 79 (77%) had MR ≤1+. The mean transmitral gradient increased from 1.9 ± 1.0 mm Hg at baseline to 3.5 ± 1.8 mm Hg at discharge (p < 0.001). CONCLUSIONS: Technical success with the new mitral valve repair system with extended clip arm was achieved in 93% of the patients. MR ≤2+ was obtained in 95 patients (93%) and MR ≤1+ in 79 (77%). The main reasons for procedural failure were acute single-leaflet device attachment associated with leaflet damage or isolated leaflet injury and often required surgical correction.
OBJECTIVES: The aim of this study was to investigate the technical success and efficacy of mitral valve edge-to-edge repair using extended clip arms. BACKGROUND: A new iteration of the MitraClip system, the MitraClip XTR, was introduced in 2018 with the aim of addressing technical limitations observed with previous versions. METHODS:Patients having received at least 1 new implant for the treatment of symptomatic mitral regurgitation (MR) were eligible for this study. RESULTS: Among the 107 patients (mean age 76 ± 9 years, 69% men) included in this study, the etiology of MR was balanced, with one-half (n = 53 [50%]) classified as secondary and the remaining 54 patients having either primary (n = 40 [37%]) or mixed (n = 14 [13%]) disease. The mean number of devices implanted was 1.5 ± 0.6. Multiple device implantation was required in 46 patients (43%). Single-leaflet device attachment occurred in 4 patients and leaflet injury in 2 additional patients, requiring surgical conversion in 4 patients. Among the 102 patients discharged alive without mitral valve surgery, 95 (93%) had MR ≤2+ and 79 (77%) had MR ≤1+. The mean transmitral gradient increased from 1.9 ± 1.0 mm Hg at baseline to 3.5 ± 1.8 mm Hg at discharge (p < 0.001). CONCLUSIONS: Technical success with the new mitral valve repair system with extended clip arm was achieved in 93% of the patients. MR ≤2+ was obtained in 95 patients (93%) and MR ≤1+ in 79 (77%). The main reasons for procedural failure were acute single-leaflet device attachment associated with leaflet damage or isolated leaflet injury and often required surgical correction.
Authors: Adam S Evans; Menachem M Weiner; Shahzad Shaefi; Prakash A Patel; Matthew M Townsley; Abirami Kumaresan; Jared W Feinman; Ashley V Fritz; Archer K Martin; Toby B Steinberg; J Ross Renew; Jane L Gui; Brian Radvansky; Himani Bhatt; Sudhakar Subramani; Archit Sharma; Jacob T Gutsche; John G Augoustides; Harish Ramakrishna Journal: J Cardiothorac Vasc Anesth Date: 2019-11-09 Impact factor: 2.628
Authors: Livia Gheorghe; Alfonso Ielasi; Benno J W M Rensing; Frank D Eefting; Leo Timmers; Azeem Latib; Martin J Swaans Journal: Front Cardiovasc Med Date: 2019-10-18
Authors: Zhang Xiling; Thomas Puehler; Lars Sondergaard; Derk Frank; Hatim Seoudy; Baland Mohammad; Oliver J Müller; Stephanie Sellers; David Meier; Janarthanan Sathananthan; Georg Lutter Journal: J Clin Med Date: 2022-06-13 Impact factor: 4.964
Authors: Faisal Khan; Mirjam Winkel; Geraldine Ong; Nicolas Brugger; Thomas Pilgrim; Stephan Windecker; Fabien Praz; Neil Fam Journal: Front Cardiovasc Med Date: 2019-09-18
Authors: Mohammed Al-Hijji; Abdallah El Sabbagh; Erin A Fender; Jeremy Thaden; Charanjit S Rihal; Mackram F Eleid Journal: Heart Views Date: 2020-01-23
Authors: Katharina Schnitzler; Michaela Hell; Martin Geyer; Felix Kreidel; Thomas Münzel; Ralph Stephan von Bardeleben Journal: Curr Cardiol Rep Date: 2021-08-13 Impact factor: 2.931
Authors: Matthias Koschutnik; Varius Dannenberg; Carolina Donà; Christian Nitsche; Andreas A Kammerlander; Sophia Koschatko; Daniel Zimpfer; Martin Hülsmann; Stefan Aschauer; Matthias Schneider; Philipp E Bartko; Georg Goliasch; Christian Hengstenberg; Julia Mascherbauer Journal: J Pers Med Date: 2022-01-11